All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Neoplasms-28767682

ID	PMID	Mutation	Gene/Protein/Region	Disease	Description	Detail
1	28767682	G7219C	LCR	Uterine Cervical Neoplasms	G R S L T	View
2	28767682	C7886G	LCR	Uterine Cervical Neoplasms	G R S L T	View
3	28767682	A7830C	LCR	Uterine Cervical Neoplasms	G R S L T	View
4	28767682	G7826A	LCR	Uterine Cervical Neoplasms	G R S L T	View
5	28767682	G7521A	LCR	Uterine Cervical Neoplasms	G R S L T	View
6	28767682	T7328C	LCR	Uterine Cervical Neoplasms	G R S L T	View
7	28767682	T7743G	LCR	Uterine Cervical Neoplasms	G R S L T	View
8	28767682	A7729C	LCR	Uterine Cervical Neoplasms	G R S L T	View
9	28767682	A7730C	LCR	Uterine Cervical Neoplasms	G R S L T	View
10	28767682	A7900C	LCR	Uterine Cervical Neoplasms	G R S L T	View
11	28767682	A7507T	LCR	Uterine Cervical Neoplasms	G R S L T	View
12	28767682	C7505T	LCR	Uterine Cervical Neoplasms	G R S L T	View
13	28767682	A7660G	LCR	Uterine Cervical Neoplasms	G R S L T	View
14	28767682	A7168G	LCR	Uterine Cervical Neoplasms	G R S L T	View
15	28767682	A7174C	LCR	Uterine Cervical Neoplasms	G R S L T	View
16	28767682	A7175C	LCR	Uterine Cervical Neoplasms	G R S L T	View
17	28767682	C7270T	LCR	Uterine Cervical Neoplasms	G R S L T	View
18	28767682	G7193T	LCR	Uterine Cervical Neoplasms	G R S L T	View
19	28767682	T7176G	LCR	Uterine Cervical Neoplasms	G R S L T	View
20	28767682	T7177C	LCR	Uterine Cervical Neoplasms	G R S L T	View
21	28767682	A7636C	LCR	Uterine Cervical Neoplasms	G R S L T	View
22	28767682	C7394T	LCR	Uterine Cervical Neoplasms	G R S L T	View
23	28767682	C7395T	LCR	Uterine Cervical Neoplasms	G R S L T	View
24	28767682	T7393A	LCR	Uterine Cervical Neoplasms	G R S L T	View
25	28767682	C7310T	LCR	Uterine Cervical Neoplasms	G R S L T	View
26	28767682	A7233C	LCR	Uterine Cervical Neoplasms	G R S L	View
27	28767682	A7287C	LCR	Uterine Cervical Neoplasms	G R S L	View
28	28767682	A7289C	LCR	Uterine Cervical Neoplasms	G R S L	View
29	28767682	C24T	LCR	Uterine Cervical Neoplasms	G R S L	View
30	28767682	C31T	LCR	Uterine Cervical Neoplasms	G R S L	View
31	28767682	G7842A	LCR	Uterine Cervical Neoplasms	G R S L	View
32	28767682	T7201C	LCR	Uterine Cervical Neoplasms	G R S L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.